Skip to main content
Log in

BIII 277CL

BIII 277, BIII 281CL

  • Section 1: Neuroprotection in Stroke
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Grauert M, Bechtel WD, Ensinger HA, et al. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex. J Med Chem 1997 Aug 40: 2922–30

    Article  PubMed  CAS  Google Scholar 

  2. Grauert M, Bechtel WD, Harrison P, et al. BI-II 277 CL is a new benzomorphan derivative which acts as a noncompetitive antagonist of the NMDA receptor-channel complex without marked affinity for opioid receptors. Soc Neurosci Abstr 1993; 19: 718

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

BIII 277CL. Drugs R&D 1, 18–19 (1999). https://doi.org/10.2165/00126839-199901010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00005

Keywords

Navigation